Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Glycomimetics Inc (NQ: GLYC )

0.3805 -1.4495 (-79.21%)
Streaming Delayed Price Updated: 11:51 AM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Glycomimetics Inc

< Previous 1 2 3 Next >
Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
Via Benzinga
Topics Earnings
Exposures Financial
GlycoMimetics' Uproleselan Flunks In Late Stage Leukemia Study, Shares Sink
Get insights on GlycoMimetics Inc's Phase 3 study results for uproleselan in R/R AML patients. Explore survival rates, adverse events, and future analyses. 
Via Benzinga
Why Is Acutus Medical (AFIB) Stock Down 41% Today?
Acutus Medical stock is down on Monday after the company reported a delisting notice that will hit AFIB shares later this week. 
Via InvestorPlace
Why Is GlycoMimetics (GLYC) Stock Down 77% Today?
GlycoMimetics stock is falling on Monday with heavy trading of GLYC after posting lackluster results from a Phase 3 trial of uproleselan. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Earnings Outlook For GlycoMimetics
Via Benzinga
Earnings Outlook For GlycoMimetics
Via Benzinga
GlycoMimetics: Q1 Earnings Insights
Via Benzinga
Earnings Preview For GlycoMimetics
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Monday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
GLYC Stock Earnings: GlycoMimetics Beats EPS for Q4 2023
GLYC stock results show that GlycoMimetics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga
GlycoMimetics: A Potential Game Changer In Blood Cancers With Near-Term Catalysts
Glycomimetics' Uproleselan is expected to read out data in relapsed/refractory and elderly newly diagnosed Acute Myeloid Leukemia (AML) after 6 years in pivotal studies. 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket
Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan.... 
Via Benzinga
Earnings Scheduled For November 3, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
Via Benzinga
GlycoMimetics: A Breakthrough In Hematopoietic Stem Cell Transplantation
Blood cancers such as AML, MM, and MDS affect a terrible toll on patients and their loved ones. Glycomimetics may be such a company that can offer patients suffering from various blood cancers hope... 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million. 
Via Benzinga
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
$3M Bet On This Biotechnology Stock? Check Out These 3 Penny Stocks Insiders Are Buying
The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
Pagaya Technologies To Rally Around Over 120%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc boosted the price target for Twilio Inc. (NYSE: TWLO) from $77 to $89. Keybanc analyst Thomas Blakey maintained an Overweight rating on the stock. Twilio shares gained 6.4% to close at $66.05... 
Via Benzinga
Nasdaq Surges 90 Points; Credo Technology Group Shares Slide
U.S. stocks turned mostly higher toward the end of trading, with the Nasdaq Composite gaining around 90 points on Wednesday. The Dow traded down 0.01% to 34,085.88 while the NASDAQ rose 0.76% to... 
Via Benzinga
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL. 
Via Benzinga
Gold Down 1%; Roblox Shares Spike Higher
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 100 points on Wednesday. The Dow traded down 0.34% to 33,974.46 while the NASDAQ rose 0.22% to 11,986.30. The... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Dips 200 Points; US Retail Sales Rise 3%
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.61% to 33,880.45 while the NASDAQ fell... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.